Introduction
At the time of the introduction of high-energy electrons into radiotherapy, there were controversies amongst radio biologists and radiotherapists about the following problems:
(1) The RBE of high-energy electron beams with respect to conventional or high-energy x-ray beams (2) the existence of a possible "therapeutic differential effect" (i.e., that the ratio of tumor response to normal tissue response may be different for electron and photon beams) (3) the practical consequences of the above in radiotherapy, concerning, in particular, when one should use electron beam therapy in preference to photons, and the choice of the type !:lull uf ihe energy uf the electron beam accelerators. It is now generally accepted that these controversies were due. at least partly. to dosimet.ric difficult.ies which were not fully understood at that time, as indicated by Sinclair and Kohn (1964) .
The situation has been progressively clarified although it will always remain difficult, when asses~ing clinical effects, to distinguish what is to be related to the purely "physical" dose distribution and what could be related, specifically, to the radiobiulogkw prupertie:s of the electron beams. The problem of the time-dose distribution (pulsed irradiation, see Section 3.4) in electron therapy has also been raised. At the present time, it can be assumed that biological effects are not significantly modified by the pulsed characteristics of high-energy electron beams for the conditions currently encountered in radiotherapy (Hall, 1978) . However, modifications in the biological effects have been observed when large doses were delivered in very short pulses (Hornsey and Alper, 1966; Epp et al., 1968; Hornsey, 1970; Nias et al., 1973; Mill 1979) . '
Survey of the Radiobiological Data
Many experiments ha.ve been performed to determine the RBE of high-energy electrons for different types of accelerators, different beam energies, and different biological systems and biological effects under differing experimental conditions such as various absorbed-dose ·levels, various levels of oxygenation, etc. The results have been reviewed and discussed by several authors (~inclair and Kohn, 1964; Wambersie, 1967 Wambersie, , 1971 LInden, 1972; Dutreix and Wambersie, 1981) . Almost all of the radiobiological experiments carried out after 1960 on biological effects relevant in radiotherapy put the RBE of high-energy electrons in the narrow range of 0.8-0.9 with respect to conventional x rays (~150-250 kV). Data obtained for the inactivation of microorganisms or mammalian cells, and for survival in mammals, are presented in Table 10 .1. However, it should be pointed out that for some biological effects other than cellular lethality (e.g., chromosome aberrations and tumor induction) and especially for small doses, lower RBE's have been observed for high-energy electrons (as well as high-energy photons) with respect to conventional x rays (Schmid et al., 1974; Lloyd et aZ., 1975; Barendsen, 1978) . These are consistent with radiobiological expectations at small doses (NCRP, 1980) and are not applicable to radiotherapeutic situations.
Although it has been the custom to use conventional x rays as the reference radiation for RBE (ICRP-ICRU. 1962), a reference based upon high-energy photons would be more sensible in modern radiotherapy. Relatively few direct comparisons have been made, but all indicate an RBE value close to unity for high-energy electrons with respect to cobalt-60 gamma rays or high-energy x rays (Table 10 .2).
The exp'crimcnts mentioned above were made in the plateau region of the depth-dose curve, where the dose is constant over the volume in which the biological system is positioned. However, the electron spectrum varies as a function of depth and the possibility that this variation could modify the biological effects has been examined. Meaningful experiments are particularly difficult to perform due to the steep dose gradient and, thus;only biological systems which can be irradiated in thin layers can be used. Furthermore, the variation with depth of the response of some detectors (e.g., gas-filled ionization chambers) presents additional difficulties. .
The variation of RBE as a function of depth in the irradiated medium has been investigated for electron beams of different initial energy (Table 10 .3). Only data obtained with FeS04 as the reference dosimeter have been included. It can be assumed that the response of the FeS04 does not vary as a function of depth and that the dosimeter solution can occupy the same volume as the biological samples.
The more recent experimental results do not indicate any significant variation of RBE with depth (Table  10 .3). Furthermore, experiments on chromosome aberrations in Allium cepa (which was proven to be a system very sensitive to a change in radiation quality) did not show any significant RBE variation in the first millimeters of the irradiated medium, i.e., between the '''surface u and the maximum of the depth-dose curve, for a 15-MeV electron beam. Observation of skin reactions in patients lead to the same conclusion (Wambersic at al., 1974) .
It can be concluded from the available radiobiological data: Leskowitz et al.(1960) Copper et al. (1962) Mookerjeeet at. (1964) Schulz et al . . (1963) Ward (1964) Marquardt and l\!larkus(1965) Hettinger et al. ' (1965) Wambersie (1967); Wambersie and Dutreix, (1971)-revised value, Robinson and Erwin (1969) (2) that no therapeutic differential effect is expected between these radiation qualities;
(3) that there is no clinically significant. variation of RBE as a function of depth in an electron beam. Systematic clinical studies{Haaset aL, 1954; W ard, 1964; ·Flamant et al., 1967; Dutreix, 1968; Eschwege and Dutreix, 1969; Wambersie et al.; 1974) , as well asthe .generalclinical impression {Tapley, 1973; Fletcher, (1971) Fehrentz (1968) Robinson and Erwin (1969) Kim et ai. (1969) Wambersie et at (1972) Wambersie et al. (1973) a No significant RBE difference for survival level, early recovery capacity, or clone size distribution. b No significant RBE difference was found in any of the experimental conditions or endpoints:-incubation time after irradiation: 3, 6, or 9 hours-cells scored in anaphase or telophase-endpoint: average number of aberrations per cell or percentage of intact cells. Confidence interval (P = 0.05) estimated 10-15%.
1976; Ho et ai., 1976; Dutreix and Wambersie, 1981), support these radiobiological conclusions.
Theoretical Considerations
The experimental measurements of Schulz and Harder (1969) and the computations of Berger and Seltzer (1969a) and Nahum (1976) have shown that below about 0.1 MeV, the electron fluence spectrum per unit absorbed dose varies only extremely slowly with initial electron beam energy and depth. Figure 10 .1 indicates that cobalt-60 gamma rays and high-energy x rays have low-energy electron spectra that are very similar to those for electron beams, whereas the number of low-energy electrons is somewhat higher for conventional x rays. It would thus appear that the differences in the biological effects of these radiations may be predicted from differences in the electron spectra at the lowest energies. However, recent slowing-down . calculations by Hamm et ale (1978) may cast doubt on this conclusion (see Section 2.4.4).
Microdosimetric measurements have provided a further confirmation of the radiobiological and clinical data. In particular, no significant RBE differences should'beexpected between beam qualities haying similar microdosimetric characteristics; Figure 10 .2 compares the sirigle-eventspecific-en-ergy16 distributions in small sphericalvolumes(diameter 1 /-Lm) irradiated ,with high-energy electrons, high-energy and Conventionalxraysand~ cobalt-60 gammarl:iys(from Lindborg,1976). The spectra are very similar for electrons, high~energy x rays and co- 16 The specific energy (imparted) is defined in ICRU Report 33 (ICRU, 1980) as the quotient of energy imparted by ionizing radiation to matter by the mass of that matter .. 0/ unit density materi.al(from Booz, 1978) balt-60 gamma rays, whereas the spectrum for conventional x rays is shifted towards higher specific energies.
The specific-energy distributions obtained at various depths in an electron beam with initial energy of 15 MeV are compared in Fig. 10.3 . Again, the spectra are very similar and, consequently, no significant RBE difference with depth should be expected in high-energy electron beams. Yn values (about 0.5). At very low doses the 0.5 value.
seems appropriately applicable. This effect is illustrated further in Fig. 10 .4 by the specific-energy distribution for electrons and conventional x rays in a 1-JLm diameter volume at absorbed doses of 0.01, 1.0, and 10 Gy. At 0.01 Gythe single event f(Z,10) r 10 Fig. 10 .4. Single-event spectra, h(z), and multiple-event specific-energy distributions for 1 and 10 Gy, calculated from experimentally-determined single-event distributions (see Fig. 10 .2). The solid lines pertain to 8.:. Me V electrons, for which the mean number of events is 15 and 148 at 1 and 10 Gy, respectively. The dotted lines pertain to 180-kV x rays with HVL = 0.9 mm Cu. In this case, the mean number of events are 4 and 44, respectively. The normalization of the single-event distributions is the same as in Fig. 10.2 . The dose-dependent distributions are normalized to the same area as that of the single-event distributions. spectra are obtained, 'whereas at 1 and 10 Gy, the higher multiplicity of events reduces the differences between the curves. Furthermore, as the differences are small at this diameter, they will differ even less for larger volumes.
Conclusions: Implications in Radiotherapy
All the radiobiological, clinical and dosimetric data presently available indicate that there is no clinically significant RBE difference between high-energy electrons, high-energy x rays (for the energy range at present used in therapy) and cobalt-60 gamma rays. This implies that the relative advantage of high-energy electrons, compared to high-energy x rays or cobalt-60 gamma rays, is due only to their respective absorbed dose distributions. At equal absorbed dose levels, the biological effects are similar, and no therapeutic differential effect can be expected.
In practical radiotherapy, as recommended in ICRU Report 29 (ICRU, 1978b) , no conversion factor is needed when adding absorbed doses from high-energy photon and electron beams. However, one does have to take into account the RBE differences between high-energy electrons (or high-energy x rays and cobalt-60 gamma rays) and conventional x rays. In order to do this, absorbed dose values of conventional x rays should be multiplied by 1.18 (= 1/0.85) when their radio-. therapeutic effects are compared with those of highenergy electrons or photons (ICRU, 1978) .
